get a key
steadybase-$ company PDSB
account_id none on file
legal_name PDS Biotechnology Corp
ticker PDSB
cik 1472091
domain pdsbiotech.com
entry_point_account_id none on file
name PDS Biotechnology Corporation
exchange Nasdaq
sector Health Care
hq Princeton, NJ, United States
calls 0 filings 3 executives 7 family 0
why_nownone on file
callsnone on file
filings
Although we believe we will reduce expenses in the near term from historical levels, such expenses will begin to increase as the planned Phase 2 PDS0301 clinical trial is initiated.

filing / Aug 13, 2026 / receipt

Directors may also be reimbursed for reasonable out-of-pocket business expenses authorized by the board of directors or a committee that are incurred in connection with attending conferences or meetings with management in accordance with a travel policy, as may be in effect from time to time.

filing / Jun 26, 2026 / receipt

This process, which is commonly referred to as “householding,” potentially means extra convenience for stockholders and cost savings for companies.

filing / Jun 26, 2026 / receipt

executives
Andrew Saik Chief Financial Officer - receipt
Daniel Brennan Chief Operating Officer - receipt
Frank Bedu-Addo Chief Executive Officer - receipt
Rosemary A. Crane director - receipt
Stephen Glover director - receipt
Van Voorhees Chief Financial Officer - receipt
W. Bradford Middlekauff Senior Vice President - receipt
familynone on file
upcoming
2026-11-12 earnings call scheduled ir
changes
2020-12-09 Chief Financial Officer, appointed sec_8k
2019-04-08 director, appointed sec_8k
2019-03-18 Chief Executive Officer, appointed sec_8k
2017-11-01 Chief Financial Officer, appointed sec_8k
2017-09-19 director, appointed sec_8k
2016-10-18 Chief Operating Officer, appointed sec_8k
2015-11-05 Senior Vice President, appointed sec_8k
mcp_package_hint
steadybase-$